MCFT
MasterCraft Boat Holdings, Inc.
MCFT offers stronger fundamentals, but that advantage does not outweigh its weaker overall profile.
TSLA
Tesla, Inc.
TSLA has the edge over MCFT overall, supported by stronger modeled upside and lower modeled downside.
MCFT Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Stable | |
| Healthy | |
| Strong |
MCFT's revenue, cash flow and balance sheet are currently healthy, and its profitability is stable.
TSLA Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Stable | |
| Under pressure | |
| Strong |
TSLA's revenue and balance sheet are currently healthy, and its profitability is stable, but its cash flow is under pressure.
MCFT PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 6.7x | $1.21 | -94% |
| Fair | 9.3x | $1.67 | -92% |
| Expensive | 24x | $4.36 | -80% |
| Current | 120x | $21.59 | — |
Historical ranges are pointers, not guarantees.
MCFT's PE is in its expensive range at 120x.
TSLA PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 60x | $54.70 | -86% |
| Fair | 174x | $158 | -60% |
| Forward | 196x | $397 | — |
| Expensive | 415x | $378 | -4.9% |
| Current | 437x | $397 | — |
Historical ranges are pointers, not guarantees.
TSLA has the edge over MCFT in the historical PE scenario, which offers more potential upside but is not a forecast.
MCFT Forward outlook
There aren't enough analyst estimates for MCFT to show an outlook.
TSLA Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Growth | |
| Growth | |
| Stable | |
| Limited | |
| Low |
Analysts expect earnings and revenue growth for TSLA, with profitability holding steady. However, they disagree widely on these estimates.
MCFT Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | $0.18 | -81% |
| Q2 2026 | -$0.10 | -123% |
| Q1 2026 | $0.68 | +$1.05 |
| Q4 2025 | $0.96 | +$1.34 |
| Q3 2025 | $0.97 | +$1.18 |
| Q2 2025 | $0.44 | -4.3% |
| Q1 2025 | -$0.37 | -117% |
| Q4 2024 | -$0.38 | -112% |
MCFT has the edge over TSLA on earnings, with more consistent year-over-year improvement.
TSLA Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $2.03 | +123% |
| Q3 2026 | $0.91 | -39% |
| Q2 2026 | $1.08 | -38% |
| Q1 2026 | $1.09 | -40% |
| Q4 2025 | $1.08 | -47% |
| Q3 2025 | $1.50 | -59% |
| Q2 2025 | $1.73 | -51% |
| Q1 2025 | $1.82 | -53% |
| Q4 2024 | $2.04 | -53% |
TSLA's earnings per share have fallen from their peak: $0.91 over the past year, against $4.30 in late 2023.
MCFT Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $154.1M | +123% |
| Q2 2026 | $129.9M | +63% |
| Q1 2026 | $78.2M | +3% |
| Q4 2025 | $71.8M | +13% |
| Q3 2025 | $69M | +5.6% |
| Q2 2025 | $79.5M | +18% |
| Q1 2025 | $76M | -21% |
| Q4 2024 | $63.4M | -36% |
MCFT has the edge over TSLA on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 7.8% | +2.3 points |
| Q2 2026 | -4.9% | -12 points |
| Q1 2026 | -1.7% | -7.1 points |
| Q4 2025 | 3.8% | +3.5 points |
| Q3 2025 | 5.5% | +3.9 points |
| Q2 2025 | 7.5% | +25 points |
| Q1 2025 | 5.4% | +1.2 points |
| Q4 2024 | 0.3% | -6.8 points |
MCFT has the edge over TSLA on profitability, with a higher operating margin.
TSLA Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $28B | -0.2% |
| Q2 2026 | $28.2B | +26% |
| Q1 2026 | $22.4B | +16% |
| Q4 2025 | $24.9B | -3.1% |
| Q3 2025 | $28.1B | +12% |
| Q2 2025 | $22.5B | -12% |
| Q1 2025 | $19.3B | -9.2% |
| Q4 2024 | $25.7B | +2.1% |
TSLA's revenue has picked up after two years of holding roughly level: $28B last quarter, about level with the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 2.6% | -3.2 points |
| Q2 2026 | 1.4% | -2.7 points |
| Q1 2026 | 4.2% | +2.1 points |
| Q4 2025 | 5.7% | -0.5 points |
| Q3 2025 | 5.8% | -5 points |
| Q2 2025 | 4.1% | -2.2 points |
| Q1 2025 | 2.1% | -3.4 points |
| Q4 2024 | 6.2% | -2 points |
TSLA's operating margin was 2.6% last quarter, down 3.2 points from the same quarter a year ago, near the bottom of its range since 2019.
MCFT Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $2.9M | +$12.8M |
| Q2 2026 | $14.6M | -18% |
| Q1 2026 | $3.8M | -13% |
| Q4 2025 | $14M | +245% |
| Q3 2025 | -$9.9M | -5083% |
| Q2 2025 | $17.9M | +$31.4M |
| Q1 2025 | $4.3M | +$5.2M |
| Q4 2024 | $4M | -83% |
MCFT has the edge over TSLA on cash flow, with more consistent year-over-year improvement.
TSLA Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $1.5B | -62% |
| Q2 2026 | -$1.1B | -848% |
| Q1 2026 | $1.4B | +117% |
| Q4 2025 | $1.4B | -30% |
| Q3 2025 | $4B | +46% |
| Q2 2025 | $146M | -89% |
| Q1 2025 | $664M | +$3.2B |
| Q4 2024 | $2B | -1.6% |
TSLA still generates free cash flow, though less than at its 2025 peak: $3.3B over the past year.
MCFT Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +51% | +8.2M shares |
| 1 year | +48% | +7.9M shares |
| 3 years | +39% | +6.8M shares |
| 5 years | +28% | +5.3M shares |
| Available history | +30% | +5.5M shares |
MCFT has 24M diluted shares, up 48% from a year ago.
| Quarter | Spent |
|---|---|
| Q3 2026 | $4.8M |
| Q2 2026 | $12,000 |
| Q1 2026 | — |
| Q4 2025 | $15,000 |
| Q3 2025 | $2.3M |
| Q2 2025 | $4.5M |
| Q1 2025 | $749,000 |
| Q4 2024 | $749,000 |
MCFT spent $5M buying back its own shares over the past year, down 42% from the year before.
TSLA Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | 0% | +1M shares |
| 1 year | +0.4% | +15M shares |
| 3 years | +1.4% | +48M shares |
| 5 years | +5.1% | +172M shares |
| Available history | +33% | +886M shares |
TSLA has the edge over MCFT on shareholder dilution, with a more favorable share count trend.
MCFT Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -1.8x | Net Cash |
| Q2 2026 | -3.5x | Net Cash |
| Q1 2026 | -3.7x | Net Cash |
| Q4 2025 | -2.2x | Net Cash |
| Q3 2025 | -1.4x | Net Cash |
| Q2 2025 | -1.4x | Net Cash |
| Q1 2025 | -8.8x | Net Cash |
| Q4 2024 | -10.1x | Net Cash |
MCFT has the edge over TSLA on leverage, with a lower net debt burden relative to earnings.
TSLA Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -1.1x | Net Cash |
| Q2 2026 | -0.8x | Net Cash |
| Q1 2026 | -0.9x | Net Cash |
| Q4 2025 | -1.1x | Net Cash |
| Q3 2025 | -1.4x | Net Cash |
| Q2 2025 | -1.1x | Net Cash |
| Q1 2025 | -1.1x | Net Cash |
| Q4 2024 | -1.0x | Net Cash |
TSLA has more cash than debt.
MCFT Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 49.0 | Neutral |
| Stochastic | 32.4 | Neutral |
MCFT's weekly RSI is 49 (neutral) and its Stochastic is 32 (neutral).
TSLA Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 54.3 | Neutral |
| Stochastic | 72.6 | Neutral |
TSLA's weekly RSI is 54 (neutral) and its Stochastic is 73 (neutral).
MCFT PE vs Consumer Cyclical Sector
| Metric | MCFT | Sector median | Relative |
|---|---|---|---|
| PE | 120x | 18x | 565% above |
| PE % | 100 | 47 | 53 pts above |
MCFT has the edge over TSLA on valuation relative to its sector.
TSLA PE vs Consumer Cyclical Sector
| Metric | TSLA | Sector median | Relative |
|---|---|---|---|
| PE | 437x | 18x | 2,324% above |
| PE % | 84 | 47 | 37 pts above |
TSLA is trading at 437x earnings, a 2324% premium to the Consumer Cyclical sector's median of 18x.
MCFT Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $20.4 | 6.1% above |
| 20 week MA | $22.3 | 3.2% below |
| 50 week MA | $22.1 | 2.4% below |
| 100 week MA | $20.5 | 5.2% above |
| 200 week MA | $22.0 | 1.8% below |
MCFT's trend is mixed: it's above two of its five weekly moving averages, and 1.8% below its 200-week average.
TSLA Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $376.0 | 5.7% above |
| 20 week MA | $364.0 | 9.2% above |
| 50 week MA | $393.6 | 1% above |
| 100 week MA | $372.1 | 6.8% above |
| 200 week MA | $296.9 | 34% above |
TSLA has the edge over MCFT on trend strength, trading above more of its moving averages.
MCFT Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $15.4 | $26.7 | +73% |
| 2021 | $26.7 | $26.3 | -1.6% |
| 2022 | $26.3 | $26.2 | -0.3% |
| 2023 | $26.2 | $22.6 | -14% |
| 2024 | $22.6 | $18.7 | -17% |
| 2025 | $18.7 | $19.5 | +4.1% |
| 2026 YTD | $19.5 | $21.6 | +11% |
MCFT has the edge over TSLA on returns for 2026, with the stronger performance.
TSLA Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $28.7 | $220.6 | +669% |
| 2021 | $220.6 | $355.7 | +61% |
| 2022 | $355.7 | $123.2 | -65% |
| 2023 | $123.2 | $248.5 | +102% |
| 2024 | $248.5 | $431.7 | +74% |
| 2025 | $431.7 | $475.2 | +10% |
| 2026 YTD | $475.2 | $397.5 | -16% |
TSLA's yearly returns have swung widely, from +669% in 2020 to −65% in 2022. It's down 16% so far in 2026.